Fernand Labrie
Publications
Page 5 of 8, showing 50 records out of 362 total, starting on record 201, ending on 250
| Publication | Category | Year |
|---|---|---|
| 162. Labrie, F., Crawford, D.; (1995) Anti-androgens in treatment of prostate cancer. Lancet, 346: 1030-1031. | Prostate Cancer | 1995 |
| 161. Labrie, F., Cusan, L., Dupont, A., Gomez, J.-L., Simard, J., Luu-The, V., Pelletier, G., Labrie, C., Bélanger, A. (1996) Androgen receptor antagonists (Chapter 28), in: Adashi, E.Y., Rock, J.A. et Rosenwaks, Z., eds: Reproductive Endocrinology, Surgery and Technology, Philadelphia, Lippincott-Raven Publishers, pp 559-583. | Prostate Cancer | 1996 |
| 160. Labrie, F., Cusan, L., Gomez, J.-L., Bélanger, A., Candas, B. (1999) Long-term combined androgen blockade alone for localized prostate cancer. Mol. Urol., 3: 217-226. | Prostate Cancer | 1999 |
| 159. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Bélanger, A., Candas, B. (1996) Combination therapy in localized prostate cancer (Chapter 4), in: Schroder, F.H., ed. Recent Advances in Prostate Cancer and BPH, Parthenon Publishing, pp 31-43. | Prostate Cancer | 1996 |
| 158. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Bélanger, A., Candas, B. (1997) Long-term neoadjuvant and adjuvant combined androgen blockade is needed for efficacy of treatment in localized prostate cancer. Mol. Urol., 1: 253-261. | Prostate Cancer | 1997 |
| 157. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Candas, B. (1995) Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality. J. Clin. Endocrinol. Metab., 80: 2002-2013. | Prostate Cancer | 1995 |
| 156. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R., Lemay, M., Candas, B. (1995) Screening und Re-Screening des Prostatakarzinoms: Die Quebec-Studie, in Faul, P. et Altwein, J.E., eds: Screening des Prostatakarzinoms, Berlin, Springer-Verlag, pp 339-352. | Prostate Cancer | 1995 |
| 155. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R., Lemay, M., Tetu, B., Fradet, Y., Bélanger, A., Candas, B. (1997) Neoadjuvant hormonal therapy: the Canadian experience. Urology, 49: 56-64. | Prostate Cancer | 1997 |
| 154. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R., Lemay, M., Tetu, B., Fradet, Y., Candas, B. (1994) Downstaging of early stage prostate cancer before radical prostatectomy: the first randomized trial of neoadjuvant combination therapy with Flutamide and a luteinizing hormone-releasing hormone agonist. Urology, 44: 29-37. | Prostate Cancer | 1994 |
| 153. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R., Lemay, M., Tetu, B., Fradet, Y., Candas, B. (1995) Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomy. Cancer Surv. 23: 149-156. | Prostate Cancer | 1995 |
| 152. Labrie, F., Cusan, L., Séguin, C., Bélanger, A., Pelletier, G., Reeves, J., Kelly, P.A., Lemay, A., Raynaud, J.P. (1980) Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man. Int. J. Fertil., 25: 157-170. | Prostate Cancer | 1980 |
| 151. Labrie, F., Dupont, A., Bélanger, A. (1984) Complete androgen neutralization is most important in the treatment of prostate cancer, in: Harrap, K.R., Davis, W. et Calvert, A.H., eds: Cancer Chemotherapy and Selective Drug Development, Martinus Nijihoff Publishing, pp 475-479. | Prostate Cancer | 1984 |
| 150. Labrie, F., Dupont, A., Bélanger, A. (1984) Un nouveau traitement du cancer de la prostate: la suppression complète des androgènes, in: Mauvais-Jarvis, P. et Schaison, G., eds: Médecine de la reproduction masculine, Flammarion, Presses Université de Montréal, pp 367-383. | Prostate Cancer | 1984 |
| 149. Labrie, F., Dupont, A., Bélanger, A. (1985) Complete androgen blockade for the treatment of prostate cancer, in: DeVita, V.T., Hellman, S. et Rosenberg, S.A., eds: Important Advances in Oncology, Philadelphia, J.B. Lippincott, pp 193-217. | Prostate Cancer | 1985 |
| 148. Labrie, F., Dupont, A., Bélanger, A. (1986) Blocco totale degli androgeni nel trattamento del cancro della prostata. Essex Oncologia, 3-47. | Prostate Cancer | 1986 |
| 147. Labrie, F., Dupont, A., Bélanger, A. (1986) Combined therapy with an LHRH agonist and a pure antiandrogen in prostate cancer, in: Paulson, J.D., Negro-Vilar, A., Lucena, E. et Martini, L., eds: Andrology: Male Fertility and Sterility, New York, Academic Press, pp 39-55. | Prostate Cancer | 1986 |
| 146. Labrie, F., Dupont, A., Bélanger, A. (1986) LHRH analogues in prostate cancer. Lancet, Vol. I: 445-446. | Prostate Cancer | 1986 |
| 145. Labrie, F., Dupont, A., Bélanger, A. (1987) LHRH agonists and antiandrogens in prostate cancer, in: Catalona, W.J. et Ratliff, T.L., eds: Genitourinary Cancer, Boston, Martinus Nijhoff Publishing, pp 157-200. | Prostate Cancer | 1987 |
| 144. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Brochu, M., Turina, E., Pinault, S., Lacourcière, Y., Emond, J. (1989) Anti-hormone treatment in stage D2 prostate cancer patients relapsing under treatment with Flutamide and castration: addition of aminoglutethimide and low dose hydrocortisone to combination therapy. Br. J. Urol., 63: 634-638. | Prostate Cancer | 1989 |
| 143. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Giguère, M., Lacourcière, Y., Luthy, I., Bégin, D., Labrie, C., Simard, J., Monfette, G., Emond, J. (1987) Combination therapy in stage C and D prostatic cancer: rationale and 5-year clinical experience, in: Poste, G. et Fidler, I.J., eds: Cancer and Metastatic Reviews, Boston, Martinus Nijhoff Publishing, pp 615-636. | Prostate Cancer | 1987 |
| 142. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Lacourcière, Y., Monfette, G., Laberge, J.G., Emond, J., Fazekas, A.T.A., Raynaud, J.P., Husson, J.M. (1982) New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and antiandrogen. Clin. Invest. Med., 5: 267-275. | Prostate Cancer | 1982 |
| 141. Labrie, F., Dupont, A., Bélanger, A., Emond, J., Monfette, G. (1984) Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer. Proc. Natl. Acad. Sci. USA, 81: 3861-3863. | Prostate Cancer | 1984 |
| 140. Labrie, F., Dupont, A., Bélanger, A., Emond, J., Monfette, G., Luthy, I., Simard, J., Lachance, R. (1987) Flutamide in combination with castration (surgical or medical) is the standard treatment in advanced prostate cancer. J. Drug Develop., 1: 34-51. | Prostate Cancer | 1987 |
| 139. Labrie, F., Dupont, A., Bélanger, A., Giguère, M., Borsanyi, J.P., Bergeron, N., Lacourcière, Y., Emond, J., Monfette, G., Lachance, R. (1987) Combination therapy with Flutamide and castration in prostate cancer: four years of experience, in: D'Agata, R. et Chrousos, G.P., eds: Recent Advances in Adrenal Regulation and Function, New York, Raven Press, pp 209-221. | Prostate Cancer | 1987 |
| 138. Labrie, F., Dupont, A., Bélanger, A., Giguère, M., Borsanyi, J.P., Lacourcière, Y., Emond, J., Monfette, G. (1987) Combined blockade with a pure antiandrogen (Flutamide) should be used without interruption in all patients with previously untreated or treated advanved prostate cancer, in: Beaulieu, E.E., Lacobelli, S. et McGuire, W.L., eds: Endocrinology and Malignancy - Basic and Clinical Issues. Proc. First International Congress on Cancer and Hormones, London, The Parthenon Publishing Group, pp 348-360. | Prostate Cancer | 1987 |
| 137. Labrie, F., Dupont, A., Bélanger, A., Giguère, M., Borsanyi, J.P., Lacourcière, Y., Emond, J., Monfette, G., Lachance, R. (1987) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy): the minimal endocrine therapy in prostate cancer, in: McCann, S.M. et Weiner, R., eds: Integrative Neuroendocrinology: Molecular Cellular and Clinical Aspects, S. Karger, A.G. Basel, pp 220-234. | Prostate Cancer | 1987 |
| 136. Labrie, F., Dupont, A., Bélanger, A., Giguère, M., Borsanyi, J.P., Lacourcière, Y., Emond, J., Monfette, G., Lachance, R. (1987) The importance of combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) in previously untreated as well as previously treated patients with advanced prostate cancer, in: Klijn, J.G.M., Paridaens, R. et Foekens, J.A., eds: Hormonal Manipulation of Cancer: Peptides growth factors and new (anti)-steroidal agents. Monograph Series of the Europea, New York, Raven Press, pp 291-300. | Prostate Cancer | 1987 |
| 135. Labrie, F., Dupont, A., Bélanger, A., Giguère, M., Lacourcière, Y., Emond, J., Monfette, G., Bergeron, V. (1985) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J. Steroid Biochem., 23: 833-841. | Prostate Cancer | 1985 |
| 134. Labrie, F., Dupont, A., Bélanger, A., Husson, J.M., Raynaud, J.P. (1983) Nouveau traitement antihormonal avec un antiandrogène et un agoniste de la LHRH dans le cancer de la prostate. Ann. Endocrinol. (Paris), 44: 343-344. | Prostate Cancer | 1983 |
| 133. Labrie, F., Dupont, A., Bélanger, A., Labrie, C., Lacourcière, Y., Emond, J., Monfette, G., Houle, J.G., Girard, J.G., Vallières, A., Bossé, C., Delisle, R. (1984) Dramatic response of prostate cancer to complete antihormonal treatment, in: Bracci, U. et Silverio, F.D., eds: Advances in Urological Oncology and Endocrinology, Rome, Acta Medica, Edizione E Congressi, pp 233-248. | Prostate Cancer | 1984 |
| 132. Labrie, F., Dupont, A., Bélanger, A., Labrie, C., Lacourcière, Y., Raynaud, J.P., Husson, J.M., Emond, J., Houle, J.G., Girard, J.G., Monfette, G., Paquet, J.P., Vallières, A., Bossé, C., Delisle, R. (1984) Combined antihormonal treatment in prostate cancer: a new approach using an LHRH agonist or castration and an antiandrogen, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Hormones and cancer 2: Proceedings of the Second International Congress on Hormones and Cancer, New York, Raven Press, pp 533-547. | Prostate Cancer | 1984 |
| 131. Labrie, F., Dupont, A., Bélanger, A., Lachance, R. (1987) Flutamide eliminates the risk of disease flare in prostate cancer patients treated with an LHRH agonist. J. Urol., 138: 804-806. | Prostate Cancer | 1987 |
| 130. Labrie, F., Dupont, A., Bélanger, A., Lachance, R., Giguère, M. (1985) Long-term treatment with luteinizing hormone-releasing hormone agonists and maintenance of serum testosterone to castration concentrations. Br. Med. J. (Clin. Res. Ed.), 291: 369-370. | Prostate Cancer | 1985 |
| 129. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G. (1984) Combined antiandrogen blockade in adenocarcinoma of the prostate: the first application of a successful new therapeutic principle in hormone-dependent cancer, in: Arvis, G., ed. Second International Forum on Andrology, Expansion Scientifique Française, Paris, pp 163-196. | Prostate Cancer | 1984 |
| 128. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G., Bergeron, V. (1985) Antiandrogènes et agonistes de la LHRH dans le traitement du cancer de la prostate. Médecine/Sciences, 1: 435-439. | Prostate Cancer | 1985 |
| 127. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Giguère, M., Emond, J., Monfette, G. (1986) Traitement antiandrogénique combiné dans l'adénocarcinome de la prostate: première application d'un nouveau principe thérapeutique dans le cancer hormono-dépendant. Ann. Urol. (Paris), 20: 98-106. | Prostate Cancer | 1986 |
| 126. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Members of LUPCP. (1984) Complete androgen blockade at start of treatment causes a dramatic improvement of survival in advanced prostate cancer, in: Labrie, F., Bélanger, A. et Dupont, A., eds: Proceedings of the International Symposium on LHRH and its analogues: Basic and Clinical Aspects, Excerpta Medica, pp 368-379. | Prostate Cancer | 1984 |
| 125. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Raynaud, J.P., Husson, J.M., Gareau, J., Fazekas, A.T.A., Sandow, J., Monfette, G. (1983) New approach in the treatment of prostate cancer: complete instead of only partial withdrawal of androgens. Prostate, 4: 579-594. | Prostate Cancer | 1983 |
| 124. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Cusan, L., Monfette, G., Laberge, J.G., Emond, J.P., Raynaud, J.P., Husson, J.M., Fazekas, A.T.A. (1983) New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogen. J. Steroid Biochem., 19: 999-1007. | Prostate Cancer | 1983 |
| 123. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Cusan, L., Raynaud, J.P., Husson, J.M., Fazekas, A.T. (1983) New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist. Horm. Res., 18: 18-27. | Prostate Cancer | 1983 |
| 122. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Raynaud, J.P. (1983) Nouvelle approche dans le traitement du cancer de la prostate: utilisation combinée d'un agoniste de la LHRH et d'un antiandrogène. J. Pharmacol. (Paris), 14 Suppl 3: 117-135. | Prostate Cancer | 1983 |
| 121. Labrie, F., Dupont, A., Bélanger, A., Members of LUPCP (1984) Spectacular response to combined antihormonal treatment in advanced prostate cancer, in: Labrie, F. et Proulx, L., eds: Endocrinology ICS 655, Excerpta Medica, pp 450-453. | Prostate Cancer | 1984 |
| 120. Labrie, F., Dupont, A., Bélanger, A., Poyet, P., Giguère, M., Lacourcière, Y., Emond, J., Monfette, G., Borsanyi, J.P. (1986) Combined treatment with Flutamide and surgical or medical (LHRH agonist) castration in metastatic prostatic cancer. Lancet, 327: 48-49. | Prostate Cancer | 1986 |
| 119. Labrie, F., Dupont, A., Bélanger, A., Simard, J., Labrie, C., Poulin, R., Luthy, I., Veilleux, R., Lacoste, D., Marchetti, B., Cusan, L., Manhès, G., Monfette, G., Emond, J. (1988) Combination therapy with the antiandrogen Flutamide and the LHRH agonist [D-Trp6,des-Gly-NH210]LHRH ethylamide in prostate cancer: rationale and 5-year clinical experience, in: Chretien, M. et McKerns, K.W., eds: Molecular Biology of Brain and Endocrine Peptidergic Systems, New York, Plenum Press, pp 83-101. | Prostate Cancer | 1988 |
| 118. Labrie, F., Dupont, A., Bélanger, A., St-Arnaud, R., Giguère, M., Lacourcière, Y., Emond, J., Monfette, G. (1986) Combined treatment with an LHRH agonist and the antiandrogen Flutamide in prostate cancer, in: Moody, T.W., ed. Neural Endocrine Peptides and Receptors, New York, Plenum Press, pp 627-644. | Prostate Cancer | 1986 |
| 117. Labrie, F., Dupont, A., Bélanger, A., St-Arnaud, R., Giguère, M., Lacourcière, Y., Emond, J., Monfette, G. (1986) Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocrine Rev., 7: 67-74. | Prostate Cancer | 1986 |
| 116. Labrie, F., Dupont, A., Bélanger, A., St-Arnaud, R., Labrie, C., Members of LUPCP (1984) Medical castration with LHRH agonists and the need for combined treatment with an antiandrogen in prostate cancer, in: McKerns, K.W., ed. Hormonal Control of the Hypothalamic-Pituitary Gonadal Axis, New York, Plenum Press, pp 531-549. | Prostate Cancer | 1984 |
| 115. Labrie, F., Dupont, A., Cusan, L., Bélanger, A., Giguère, M., Labrie, C., Lacourcière, Y., Monfette, G., Emond, J. (1988) Combination therapy with Flutamide and [D-Trp6, des-Gly-NH210]LHRH ethylamide in stage C and D prostate cancer: Today's therapy of choice - Rationale and 5-year clinical experience. Prog. Clin. Biol. Res., 262: 11-63. | Prostate Cancer | 1988 |
| 114. Labrie, F., Dupont, A., Cusan, L., Giguère, M., Bergeron, N., Borsanyi, J.P., Lacourcière, Y., Bélanger, A., Emond, J., Monfette, G., Boucher, H., Lachance, R. (1988) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice. J. Steroid Biochem., 30: 107-117. | Prostate Cancer | 1988 |
| 113. Labrie, F., Dupont, A., Cusan, L., Giguère, M., Bergeron, N., Lacourcière, Y., Bélanger, A., Monfette, G., Emond, J. (1988) Combination therapy with Flutamide and [D-Trp6]LHRH ethylamide in advanced (stages C and D) previously untreated prostate cancer, in: Motta, M. et Serio, M., eds: Hormonal therapy of prostatic diseases: basic and clinical aspects: International Symposium, Milano, Italy, April 6-8 1987: abstracts of lectures and free communications, pp 312-333. | Prostate Cancer | 1988 |